Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BEAM

Beam Therapeutics Inc

Jun 12 • 10:29AM ET

30.02

+0.61 2.09 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: CRSP NTLA EDIT VIR BMRN INCY IONS ALNY VRTX DNLI

| Held by: ARKK XBI VTI VB IWM ARKG VBK VXF IWO IBB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.69	Insider Own	8.86%	Shs Outstand	102.74M	Perf Week	2.13%
Market Cap	3.09B	Forward P/E	-	EPS next Y	-4.62	Insider Trans	-2.46%	Shs Float	93.77M	Perf Month	-5.73%
Enterprise Value	2.13B	PEG	-	EPS next Q	-1.11	Inst Own	96.59%	Short Float	22.88%	Perf Quarter	19.34%
Income	-65.04M	P/S	18.83	EPS this Y	-445.78%	Inst Trans	3.13%	Short Ratio	10.25	Perf Half Y	9.58%
Sales	164.01M	P/B	2.65	EPS next Y	-4.56%	ROA	-4.41%	Short Interest	21.46M	Perf YTD	8.32%
Book/sh	11.33	P/C	2.55	EPS next 5Y	-	ROE	-5.69%	52W High	36.44 -17.60%	Perf Year	72.16%
Cash/sh	11.78	P/FCF	-	EPS past 3/5Y	41.92% 28.04%	ROIC	-4.64%	52W Low	15.60 92.47%	Perf 3Y	-8.96%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	31.88% 466.27%	Gross Margin	86.36%	Volatility	7.33% 6.83%	Perf 5Y	-66.17%
Dividend TTM	-	EV/Sales	12.98	EPS Y/Y TTM	86.11%	Oper. Margin	-226.58%	ATR (14)	2.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	16.99	Sales Y/Y TTM	157.97%	Profit Margin	-39.66%	RSI (14)	50.40	Recom	1.28
Dividend Gr. 3/5Y	- -	Current Ratio	16.99	EPS Q/Q	26.46%	SMA20	1.27%	Beta	2.21	Target Price	50.19
Payout	-	Debt/Eq	0.22	Sales Q/Q	324.87%	SMA50	1.49%	Rel Volume	0.75	Prev Close	29.41
Employees	511	LT Debt/Eq	0.20	Earnings	May 07 BMO	SMA200	12.50%	Avg Volume	2.09M	Price	30.02
IPO	Feb 06, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.46% 189.13%	Trades		Volume	303,648	Change	2.09%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)